Danaher | DHR - Les Charges D'Exploitation

Prix De L'Action
177.25
Variation Quotidienne
-1.32 -0.74%
Mensuellement
-5.29%
Annuel
-10.09%
Q2 Prévisions
173.46




Les Charges D'Exploitation Changement Date
Abbott USD 9.31B 104M 2026-03
Agilent USD 1.44B 27M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Boston Scientific USD 4.04B 18M 2025-12
Bruker USD 900.9M 124.3M 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 423M 1.06B 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
ESCO Technologies USD 251.27M 35.88M 2025-12
Fortive USD 897M 1.39B 2025-12
Henry Schein USD 3.25B 110M 2025-12
Illumina USD 903M 69M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
IQVIA Holdings USD 1.69B 4.47B 2025-12
Keysight Technologies USD 1.26B 38M 2025-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Medtronic USD 7.28B 16M 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Roper Industries USD 1.53B 55.4M 2026-03
Stryker USD 5.2B 505M 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Waters USD 661.85M 1.67B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12